Castle, David

Prof David Castle

Psychiatrist; Inaugural Scientific Director, Centre for Complex Interventions (CCI) at the Centre for Addictions and Mental Health (CAMH), Toronto, Canada; Professor, Department of Psychiatry, The University of Toronto Honorary Affiliation - Professor of Psychiatry at St Vincent’s Health and The University of Melbourne
David is Professor of Psychiatry at St Vincent’s Health and The University of Melbourne. He has wide clinical and research interests, encompassing schizophrenia and related disorders, bipolar disorder, OCD spectrum disorders and disorders of body image. He has a longstanding interest in the impact of licit and illicit substances on the brain and body and is actively engaged in programmes addressing the physical health of the mentally ill and the mental health of the physically ill. He has published widely in the scientific literature and is a frequent speaker at scientific meetings.

More from this expert

Clinical Articles iconClinical Articles

Professor David Castle, Chair Psychiatry St Vincent’s Hospital and University of Melbourne and Board Director Mind Medicine Australia, answers some of the big questions about the re-emerging field of psychedelic-assisted psychotherapy in this Q&A.

This article discusses the sexual side-effects of the various antidepressants and what can be done about this issue.

Monographs iconMonographs

Professor David Castle, Chair Psychiatry St Vincent’s Hospital and University of Melbourne and Board Director Mind Medicine Australia, answers some of the big questions about the re-emerging field of psychedelic-assisted psychotherapy in this Q&A.

Clinical Articles iconClinical Articles

Prof David Castle, explains why mood disorders in men are less common than in women, but keep this diagnosis in mind if behaviour is becoming violent.

Podcasts iconPodcasts

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.